I am very curious about this study.  I still can't figure out how
breastfeeding is a part of it.  I ran across a web site for the Naomi Berrie
Diabetes Center in regard to this study.  Nothing about breastfeeding...but
"formula will be suppled at no cost."  see
http://nbdiabetes.org/research/studies11.html

A Canadian web site discusses funding--Mead Johnson.

"TRIGR (Trial to Reduce Insulin-Dependent Diabetes in the Genetically at
Risk) is the largest clinical trial ever conducted in Canada and one of the
largest pediatric trials in the world. Based out of the Robarts Research
Institute in London, Ontario, this trial will determine if delaying dietary
exposure to intact foreign food proteins can reduce the risk of developing
Type 1 diabetes in children who are genetically predisposed to the disease.
The total budget for this 10-year study will exceed $50 million of which the
Canadian component includes $10 million from CIHR and a significant
contribution from the Juvenile Diabetes Research Foundation. Other funders
include the US National Institutes of Health and several European agencies.
The Mead-Johnson Division of Bristol-Myers-Squibb, Evansville, Illinois
supported the development of the TRIGR trial from its inception to the
present trial, and supplies all formulas worldwide. The Hospital for Sick
Children Foundation provided grants to support the national and international
trial development."

How will this study encourage breastfeeding?   Valerie W. McClain, IBCLC









             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html